Michael Guralnick, MD, FRCSC

Publications

• Does choice of anesthesia during stage 1 sacral neuromodulation testing influence outcomes?

  (Waldoch BT, Anderson DJ, Narveson SA, O'Connor RC, Guralnick ML.) Neurourol Urodyn. 2024 Mar;43(3):574-578 PMID: 38238985 01/19/2024

• Factors associated with recurrent urinary tract infections in spinal cord injured patients who use intermittent catheterization.

  (Everett RG, Charles DK, Foss HE, O'Connor RC, Guralnick ML.) Can J Urol. 2021 Dec;28(6):10920-10928 PMID: 34895397 12/14/2021

• Is a 50% improvement threshold adequate to justify progression from sacral neuromodulation testing to implant?

  (Charles DK, Everett RG, Prebay ZJ, Landowski TP, O'Connor RC, Guralnick ML.) Neurourol Urodyn. 2021 Aug;40(6):1524-1531 PMID: 34005836 05/19/2021

• Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction.

  (O'Connor RC, Johnson DP, Guralnick ML.) Neurourol Urodyn. 2020 Nov;39(8):2322-2328 PMID: 32866304 09/01/2020

• ICS Educational Module: Cough stress test in the evaluation of female urinary incontinence: Introducing the ICS-Uniform Cough Stress Test.

  (Guralnick ML, Fritel X, Tarcan T, Espuna-Pons M, Rosier PFWM.) Neurourol Urodyn. 2018 Jun;37(5):1849-1855 PMID: 29926966 06/22/2018

• Is mesenteric defect closure needed in urologic surgery using ileum?

  (Avallone MA, Dietrich PN, Shepherd ST, Lalehzari M, O'Connor RC, Guralnick ML.) Can J Urol. 2018 Jun;25(3):9334-9339 PMID: 29900822 06/15/2018

• International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study.

  (Rosier PFWM, Schaefer W, Lose G, Goldman HB, Guralnick M, Eustice S, Dickinson T, Hashim H.) Neurourol Urodyn. 2017 Jun;36(5):1243-1260 PMID: 27917521 12/06/2016

• Less is more-A pilot study evaluating one to three intradetrusor sites for injection of OnabotulinumtoxinA for neurogenic and idiopathic detrusor overactivity.

  (Avallone MA, Sack BS, El-Arabi A, Guralnick ML, O'Connor RC.) Neurourol Urodyn. 2017 Apr;36(4):1104-1107 PMID: 27283922 06/11/2016

• Cystectomy and Urinary Diversion for the Management of a Devastated Lower Urinary Tract Following Prostatic Cryotherapy and/or Radiotherapy.

  (Sack BS, Langenstroer P, Guralnick ML, Jacobsohn KM, O'Connor RC.) WMJ. 2016 Apr;115(2):70-3 PMID: 27197339 SCOPUS ID: 2-s2.0-84962635716 05/21/2016

• Lower urinary tract dysfunction in patients with dysautonomia.

  (Aubin MS, Shridharani A, Barboi AC, Guralnick ML, Jaradeh SS, Prieto TE, O'Connor RC.) Clin Auton Res. 2015 Dec;25(6):407-10 PMID: 26530163 11/05/2015

• Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversion.

  (Jacobsohn K, Davis TD, El-Arabi AM, Tlachac J, Langenstroer P, O'Connor RC, Guralnick ML, See WA, Schlosser R.) Can Urol Assoc J. 2015;9(5-6):E367-71 PMID: 26225179 PMCID: PMC4479652 08/01/2015

• InTone: a novel pelvic floor rehabilitation device for urinary incontinence.

  (Guralnick ML, Kelly H, Engelke H, Koduri S, O'Connor RC.) Int Urogynecol J. 2015 Jan;26(1):99-106 PMID: 25074260 SCOPUS ID: 2-s2.0-84939885788 07/31/2014